Research ArticleGeneral Nuclear Medicine
Kinetic Studies with Iodine-123-Labeled Serum Amyloid P Component in Patients with Systemic AA and AL Amyloidosis and Assessment of Clinical Value
Pieter L. Jager, Bouke P.C. Hazenberg, Eric J.F. Franssen, Piet C. Limburg, Martin H. van Rijswijk and D. Albertus Piers
Journal of Nuclear Medicine April 1998, 39 (4) 699-706;
Pieter L. Jager
Bouke P.C. Hazenberg
Eric J.F. Franssen
Piet C. Limburg
Martin H. van Rijswijk
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Kinetic Studies with Iodine-123-Labeled Serum Amyloid P Component in Patients with Systemic AA and AL Amyloidosis and Assessment of Clinical Value
Pieter L. Jager, Bouke P.C. Hazenberg, Eric J.F. Franssen, Piet C. Limburg, Martin H. van Rijswijk, D. Albertus Piers
Journal of Nuclear Medicine Apr 1998, 39 (4) 699-706;
Kinetic Studies with Iodine-123-Labeled Serum Amyloid P Component in Patients with Systemic AA and AL Amyloidosis and Assessment of Clinical Value
Pieter L. Jager, Bouke P.C. Hazenberg, Eric J.F. Franssen, Piet C. Limburg, Martin H. van Rijswijk, D. Albertus Piers
Journal of Nuclear Medicine Apr 1998, 39 (4) 699-706;
Jump to section
Related Articles
- No related articles found.
Cited By...
- A Brief Exposure to Tryptase or Thrombin Potentiates Fibrocyte Differentiation in the Presence of Serum or Serum Amyloid P
- Cardiovascular Magnetic Resonance in Clinically Suspected Cardiac Amyloidosis: Diagnostic Value of a Typical Pattern of Late Gadolinium Enhancement
- Diagnostic Performance and Prognostic Value of Extravascular Retention of 123I-Labeled Serum Amyloid P Component in Systemic Amyloidosis
- Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics